Viewing Study NCT05641493


Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2025-12-27 @ 11:59 PM
Study NCT ID: NCT05641493
Status: RECRUITING
Last Update Posted: 2023-04-10
First Post: 2022-11-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of HLX208+HLX10 in NSCLC With BRAF V600E Mutation
Sponsor: Shanghai Henlius Biotech
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module